Alkermes (ALKS) Tops Q1 EPS by 13c
Tweet
Share
E-mail
Get Alerts ALKS Hot Sheet
Price: $44.99 -0.9%
Revenue Growth %: +17.7%
Financial Fact:
Research and development: 23.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +17.7%
Financial Fact:
Research and development: 23.71M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.11, $0.13 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $251.4 million versus the consensus estimate of $233.43 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Monolithic Power Systems (MPWR) Reiterated at Buy by Stifel on Reaching $4B Target
- Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program
- Wynn Resorts plans $900M senior notes offering due 2035
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
